Equities
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

  • Revenue in JPY (TTM)3.35tn
  • Net income in JPY431.18bn
  • Incorporated1925
  • Employees47.10k
  • Location
    Takeda Pharmaceutical Co Ltd4F, 2-1-1, Nihombashihon-choCHUO-KU 103-8668JapanJPN
  • Phone+81 332782111
  • Fax+81 332782000
  • Websitehttps://www.takeda.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4502:TYO since
announced
Transaction
value
Maverick Therapeutics IncAnnounced09 Mar 202109 Mar 2021Announced-4.23%525.00m
Nihon Pharmaceutical Co LtdAnnounced24 Nov 202024 Nov 2020Announced2.49%51.04m
Data delayed at least 20 minutes, as of Sep 22 2021 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Recordati Industria Chimica e Farma SpA186.91bn46.76bn1.37tn4.36k29.257.9123.137.321.751.756.986.450.51341.574.94334,596.5012.8514.6315.9318.4172.5270.5125.0223.231.1121.960.463559.51-2.236.70-3.7512.3033.3411.84
Shionogi & Co Ltd294.74bn122.56bn2.30tn5.49k18.402.5716.697.79400.54400.54963.362,866.560.31611.333.9353,735,460.0013.1614.0414.5215.8181.8981.1841.6433.506.01--0.008725.39-10.86-0.8396-8.4610.9016.8911.74
Shanghai Fosun Pharmaceutical (Group)561.33bn74.84bn2.34tn32.26k33.993.97--4.161.731.7312.9614.770.39413.106.001,030,170.005.675.599.398.4553.1757.4114.4014.970.8424--0.361530.186.0219.1710.278.2929.146.09
Otsuka Holdings Co Ltd1.45tn152.73bn2.71tn33.15k17.401.3411.381.87279.19279.192,666.553,626.620.54442.544.0643,624,570.005.914.567.105.5768.2366.9810.858.802.08--0.097848.151.90-0.063816.507.765.320.00
Merck KGaA2.38tn350.00bn3.33tn58.41k32.034.635.581.406.286.2842.6344.370.42652.005.03319,230.306.314.418.195.8461.6963.6914.7810.980.673913.770.38269.718.566.4253.7912.3717.665.92
Astellas Pharma Inc1.27tn100.86bn3.49tn15.46k34.552.5120.112.7554.3054.30683.30746.350.56321.593.5082,090,140.004.489.296.1612.6280.4077.907.9514.251.22--0.201540.02-3.94-1.86-38.29-9.04-8.105.59
Bayer AG5.34tn-968.82bn5.76tn99.44k--1.48--1.08-7.70-2.7342.4530.930.35011.953.18418,764.70-6.35-0.9407-8.72-1.2052.7260.72-18.13-2.480.799511.420.569---4.93-2.12-751.15---0.7993-4.06
Takeda Pharmaceutical Co Ltd3.35tn431.18bn5.95tn47.10k13.731.135.991.78273.81273.812,124.963,339.330.26481.304.1571,032,620.003.411.974.012.4470.1868.6412.897.100.99455.310.4568124.20-2.8412.09749.9036.2222.750.00
Chugai Pharmaceutical Co Ltd809.05bn230.58bn6.93tn7.56k29.466.45--8.57140.15140.15491.78639.860.68921.433.54107,088,600.0019.6412.7623.0615.2167.2457.6728.5019.273.20413.490.0046.7614.689.5536.2928.5719.4425.98
Data as of Sep 22 2021. Currency figures normalised to Takeda Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

17.77%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 31 Aug 202164.93m4.10%
BlackRock Fund Advisorsas of 01 Jul 202151.07m3.23%
The Vanguard Group, Inc.as of 03 Sep 202137.21m2.35%
Nikko Asset Management Co., Ltd.as of 02 Sep 202130.33m1.92%
Daiwa Asset Management Co. Ltd.as of 31 Aug 202127.23m1.72%
BlackRock Japan Co., Ltd.as of 30 Jun 202123.22m1.47%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 02 Sep 202114.74m0.93%
Baillie Gifford & Co.as of 16 Sep 202111.81m0.75%
Geode Capital Management LLCas of 16 Sep 202110.70m0.68%
Causeway Capital Management LLCas of 31 Jul 20219.87m0.62%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
image